In order to ascertain the potential correlation between changes in serum FAP levels and the progression of glioma during treatment, a series of serum samples were collected from a cohort of 33 patients for the purpose of FAP analysis (Fig. 3 I). The gene discussed is FAP; the disease is glioma.